BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 18172262)

  • 1. Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme.
    Hutterer M; Knyazev P; Abate A; Reschke M; Maier H; Stefanova N; Knyazeva T; Barbieri V; Reindl M; Muigg A; Kostron H; Stockhammer G; Ullrich A
    Clin Cancer Res; 2008 Jan; 14(1):130-8. PubMed ID: 18172262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival.
    Gustafsson A; Martuszewska D; Johansson M; Ekman C; Hafizi S; Ljungberg B; Dahlbäck B
    Clin Cancer Res; 2009 Jul; 15(14):4742-9. PubMed ID: 19567592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells.
    Vouri M; An Q; Birt M; Pilkington GJ; Hafizi S
    Oncotarget; 2015 Jun; 6(18):16183-97. PubMed ID: 25980499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AXL-GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases.
    Wu X; Ma W; Zhou Q; Yan H; Lim ZF; Huang M; Deng C; Yu X; Su H; Komo S; Yang H; Zhang X; Wen S; Zhang Z; Ma PC
    J Cancer Res Clin Oncol; 2017 Oct; 143(10):1947-1957. PubMed ID: 28551766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corosolic Acid Attenuates the Invasiveness of Glioblastoma Cells by Promoting CHIP-Mediated AXL Degradation and Inhibiting GAS6/AXL/JAK Axis.
    Sun LW; Kao SH; Yang SF; Jhang SW; Lin YC; Chen CM; Hsieh YH
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway.
    O'Donnell K; Harkes IC; Dougherty L; Wicks IP
    Am J Pathol; 1999 Apr; 154(4):1171-80. PubMed ID: 10233855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher expression of receptor tyrosine kinase Axl, and differential expression of its ligand, Gas6, predict poor survival in lung adenocarcinoma patients.
    Ishikawa M; Sonobe M; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Date H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3(Suppl 3):S467-76. PubMed ID: 23242819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of Gas6/Axl in human ovarian cancers.
    Sun W; Fujimoto J; Tamaya T
    Oncology; 2004; 66(6):450-7. PubMed ID: 15452374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of growth arrest-specific protein 6 and Axl molecules in the left internal mammary artery of patients undergoing coronary artery bypass grafting.
    Lee CH; Shieh YS; Tsai CS; Hung YJ; Tsai YT; Lin CY
    J Clin Pathol; 2014 Jun; 67(6):506-11. PubMed ID: 24567414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine endometrial cancers.
    Sun WS; Fujimoto J; Tamaya T
    Ann Oncol; 2003 Jun; 14(6):898-906. PubMed ID: 12796028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases, Axl and Sky, in human uterine endometrium and ovarian endometriosis.
    Sun WS; Misao R; Iwagaki S; Fujimoto J; Tamaya T
    Mol Hum Reprod; 2002 Jun; 8(6):552-8. PubMed ID: 12029073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo.
    Onken J; Torka R; Korsing S; Radke J; Krementeskaia I; Nieminen M; Bai X; Ullrich A; Heppner F; Vajkoczy P
    Oncotarget; 2016 Mar; 7(9):9876-89. PubMed ID: 26848524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier.
    Seike M; Kim CH; Zou F; Noro R; Chiba M; Ishikawa A; Κunugi S; Kubota K; Gemma A
    Oncol Rep; 2017 Jun; 37(6):3261-3269. PubMed ID: 28440492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of receptor-type tyrosine kinase, Axl, and its ligand, Gas6, in pediatric thyroid carcinomas around chernobyl.
    Ito M; Nakashima M; Nakayama T; Ohtsuru A; Nagayama Y; Takamura N; Demedchik EP; Sekine I; Yamashita S
    Thyroid; 2002 Nov; 12(11):971-5. PubMed ID: 12490074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the growth arrest-specific gene 6 (GAS6) in leukemia and lymphoma cell lines.
    Dirks W; Rome D; Ringel F; Jäger K; MacLeod RA; Drexler HG
    Leuk Res; 1999 Jul; 23(7):643-51. PubMed ID: 10400186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases.
    Fiebeler A; Park JK; Muller DN; Lindschau C; Mengel M; Merkel S; Banas B; Luft FC; Haller H
    Am J Kidney Dis; 2004 Feb; 43(2):286-95. PubMed ID: 14750094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor tissue and plasma levels of AXL and GAS6 before and after tyrosine kinase inhibitor treatment in EGFR-mutated non-small cell lung cancer.
    Nonagase Y; Takeda M; Azuma K; Hayashi H; Haratani K; Tanaka K; Yonesaka K; Ishii H; Hoshino T; Nakagawa K
    Thorac Cancer; 2019 Oct; 10(10):1928-1935. PubMed ID: 31419057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.
    Vajkoczy P; Knyazev P; Kunkel A; Capelle HH; Behrndt S; von Tengg-Kobligk H; Kiessling F; Eichelsbacher U; Essig M; Read TA; Erber R; Ullrich A
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5799-804. PubMed ID: 16585512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway.
    Sawabu T; Seno H; Kawashima T; Fukuda A; Uenoyama Y; Kawada M; Kanda N; Sekikawa A; Fukui H; Yanagita M; Yoshibayashi H; Satoh S; Sakai Y; Nakano T; Chiba T
    Mol Carcinog; 2007 Feb; 46(2):155-64. PubMed ID: 17186543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling.
    Dong M; Xiao Q; Hu J; Cheng F; Zhang P; Zong W; Tang Q; Li X; Mao F; He Y; Yu X; Wan F; Lei T; Guo D; Wang B
    Cancer Gene Ther; 2020 Dec; 27(12):878-897. PubMed ID: 31988476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.